Dormancy in Breast Cancer, the Role of Autophagy, lncRNAs, miRNAs and Exosomes.
Publication Date
2022-05-09Journal Title
Int J Mol Sci
ISSN
1422-0067
Publisher
MDPI
Volume
23
Issue
9
Language
en
Type
Article
This Version
VoR
Metadata
Show full item recordCitation
Jahangiri, L., & Ishola, T. (2022). Dormancy in Breast Cancer, the Role of Autophagy, lncRNAs, miRNAs and Exosomes.. Int J Mol Sci, 23 (9) https://doi.org/10.3390/ijms23095271
Abstract
Breast cancer (BC) is the most frequently diagnosed cancer in women for which numerous diagnostic and therapeutic options have been developed. Namely, the targeted treatment of BC, for the most part, relies on the expression of growth factors and hormone receptors by these cancer cells. Despite this, close to 30% of BC patients may experience relapse due to the presence of minimal residual disease (MRD) consisting of surviving disseminated tumour cells (DTCs) from the primary tumour which can colonise a secondary site. This can lead to either detectable metastasis or DTCs entering a dormant state for a prolonged period where they are undetectable. In the latter, cells can re-emerge from their dormant state due to intrinsic and microenvironmental cues leading to relapse and metastatic outgrowth. Pre- and clinical studies propose that targeting dormant DTCs may inhibit metastasis, but the choice between keeping them dormant or forcing their "awakening" is still controversial. This review will focus on cancer cells' microenvironmental cues and metabolic and molecular properties, which lead to dormancy, relapse, and metastatic latency in BC. Furthermore, we will focus on the role of autophagy, long non-coding RNAs (lncRNAs), miRNAs, and exosomes in influencing the induction of dormancy and awakening of dormant BC cells. In addition, we have analysed BC treatment from a viewpoint of autophagy, lncRNAs, miRNAs, and exosomes. We propose the targeted modulation of these processes and molecules as modern aspects of precision medicine for BC treatment, improving both novel and traditional BC treatment options. Understanding these pathways and processes may ultimately improve BC patient prognosis, patient survival, and treatment response.
Keywords
dormancy, breast cancer, autophagy, lncRNAs, miRNAs, exosomes, treatment
Identifiers
External DOI: https://doi.org/10.3390/ijms23095271
This record's URL: https://www.repository.cam.ac.uk/handle/1810/337002
Rights
Licence:
https://creativecommons.org/licenses/by/4.0/
Statistics
Total file downloads (since January 2020). For more information on metrics see the
IRUS guide.